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Abstract 
 
High-Dose Chemotherapy (HDC) followed by Stem Cell Transplantation (SCT) has been proven to be 
beneficial for a variety of haematological diseases, solid tumours and immune disorders. Despite 
improved care and treatment, SCT continues to produce significant long-term complications with 
impaired functioning and distressing symptoms. In this thesis the overall aim was to improve our 
knowledge about how SCT patients experience different types of transplantations and the effect it may 
have on their Health-Related Quality of Life (HRQoL) during the first year after SCT. Semi structured 
interviews were performed and two questionnaires, the European Organization for Research and 
Treatment of Cancer Quality of Life questionnaire (EORTC QLQ-C30) and the module, High-Dose-
Chemotherapy (HDC-19), were administered. Health-related quality of life after allogeneic SCT 
following Reduced Intensity Conditioning (RIC) and MyeloAblative Conditioning (MAC) were 
compared. Both groups showed a similar pattern of development over time in functioning and 
symptoms, albeit more severe in the MAC group. One year after SCT there were no significant 
differences between the groups in global Quality of Life (QoL). However, RIC patients improved in 
global QoL back to baseline earlier compared to MAC patients. When allogeneic and autologous 
patients were compared, RIC patients seemed to recover in the same way as autologous patients and 
these two groups were closer in their scoring compared to MAC patients. The results emphasize the 
need to separate the two allogeneic groups when evaluating HRQoL after SCT. Symptoms related to 
the digestive system like; dry mouth, sore mouth, appetite loss and change of taste together with 
fatigue were among the most frequent reported symptoms throughout the SCT period for all three 
groups. In the MAC group, symptoms of dry mouth and change of taste even increased, and one year 
after SCT these symptoms were more pronounced compared to baseline. Four themes emerged from 
the data analysis of the interviews and illustrate how the participants described their life from 
discharge until one year after SCT; obstacles on the road to normality, to be part of a normal life, the 
chance to be cured overshadow everything and new values in life. The patients described that they felt 
restricted in life and had problems to manage the response from family and friends. Stem cell 
transplantation had changed their opportunities in life, meaning that plans for the future had to be 
altered, sometimes in a negative way. Stem cell transplantation is a demanding procedure that affects 
the patients HRQoL over a long period of time. Alleviation and management of distressing symptoms 
and impaired functioning are some of the most important tasks for the health care providers in order to 
contribute to a better health and life situation for SCT survivors.   
 
Keywords: health-related quality of life, stem cell transplantation, myeloablative conditioning, 
reduced intensity conditioning, symptoms, functioning 
 
ISBN 978-91-628-8179-5                      Gothenburg 2010 
